Global Trigeminal Neuralgia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Image

Global Trigeminal Neuralgia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431638
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Plc
  • Biogen, Inc.
  • GlaxoSmithKline Plc.
  • Kineta Inc.
  • Merz Pharma GmbH & Co.
  • MORE
Trigeminal Neuralgia Treatment Market - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2017 - 2025, the trigeminal neuralgia treatment market was valued at US$ 46.53 Mn in 2016, and is expected to reach US$ 99.17 Mn by 2025, expanding at a CAGR of 7.60% from 2017 to 2025.

Market Insights

Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. According to the International Association for the Study of Pain the incidence of Trigeminal Neuralgia is 12 per 100,000 persons per year. The etiology includes the compression of blood vessels, degeneration of arteries, myelin sheath infiltration and idiopathy. Trigeminal neuralgia is most commonly seen after the age of 40 years. Incidence is higher in females as compared to males. The currently available treatment comprises of drug based therapy such as anticonvulsant, NSAIDs and opioids. The surgical procedures are an option to the patients who develop resistance to the drug therapy. The key factors assisting the growth of trigeminal neuralgia treatment market are growing prevalence of chronic pain disorders coupled with growing public awareness, rising healthcare expenditure in the developed and developing regions and developing technology of pharmaceutical companies leading to more target specific drugs with lesser side effects. On the other hand, insufficient funding in emerging countries and high cost involved in the treatment of the disease are hindering the market growth of trigeminal neuralgia treatment.

Pipeline Analysis

Pipeline of trigeminal neuralgia is dense and comprises of combination of chemical-based and biological drugs. However, the no. of chemical-based drug molecules are more in the phase III of clinical trials compared to biological drugs. We have estimated sales of very specific molecules based on the type (chemical-based or biological), disease prevalence, sponsor, depicted peak sales by leading market experts and other factors.

Key Market Movements:
  • Rising prevalence of chronic pain disorders in developed and developing countries
  • Age plays crucial role in trigeminal neuralgia and aging population in developed countries is expected to boost the market
  • High public awareness is assisting the trigeminal neuralgia diagnostics market and ultimately the treatment market
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Plc
  • Biogen, Inc.
  • GlaxoSmithKline Plc.
  • Kineta Inc.
  • Merz Pharma GmbH & Co.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Trigeminal Neuralgia Treatment Market Portraiture
2.2 Global Trigeminal Neuralgia Treatment Market, by Treatment, 2016 (US$ Mn)
2.3 Global Trigeminal Neuralgia Treatment Market, by Geography, 2016 (Value %)

Chapter 3 Global Trigeminal Neuralgia Treatment Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Growing prevalence of chronic pain disorders have generated demand for Trigeminal Neuralgia Treatment
3.2.2 Rise in aging population and public awareness have generated demand for Trigeminal Neuralgia Treatment
3.3 Market Restraints
3.3.1 Insufficient funding in emerging markets and high cost involved in treatment of Trigeminal Neuralgia
3.4 Market Opportunities
3.4.1 Improved Healthcare expenditure due to patient oriented reimbursement policies and tapping market of unmet medical needs
3.5 Porter's Five Forces Model
3.6 Attractive Investment Proposition
3.7 Market Competition Assessment: Trigeminal Neuralgia Treatment, by Key Players

Chapter 4 Global Trigeminal Neuralgia Treatment Market, By Type of Treatment
4.1 Introduction
4.2 Drug Based
4.2.1 Anticonvulsant
4.2.2 NSAIDs
4.2.3 Opioids
4.3 Surgery
4.3.1 Rhizotomy
4.3.2 Stereotactic radiosurgery
4.3.3 Micro vascular decompression

Chapter 5 Global Trigeminal Neuralgia Treatment Market, By Geography
5.1 Preface
5.2 North America
5.3 Europe
5.4 Asia Pacific
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Allergan Plc
6.1.1 Allergan Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.2 Biogen, Inc.
6.2.1 Biogen, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.3 Kineta Inc.
6.3.1 Kineta Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.4 Merz Pharma GmbH & Co.
6.4.1 Merz Pharma GmbH & Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.5 Trigemina Inc.
6.5.1 Trigemina Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.6 Abbott Laboratories
6.6.1 Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.7 Pfizer Inc.
6.7.1 Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.8 GlaxoSmithKline Plc.
6.8.1 GlaxoSmithKline Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.9 Novartis
6.9.1 Novartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
6.10 Shire
6.10.1 Shire: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)

List of Figures
Fig. 1 Trigeminal Neuralgia Treatment Market: Research Methodology
Fig. 2 Global Trigeminal Neuralgia Treatment Market, by Treatment 2016 (US$ Mn)
Fig. 3 Global Trigeminal Neuralgia Treatment Market, by Geography, 2016 (Value %)
Fig. 4 Porter's Five Forces Model: Trigeminal Neuralgia Treatment Market
Fig. 5 Attractive Investment Proposition, by Geography,2016
Fig. 6 Market Positioning of Key Trigeminal Neuralgia Treatment Market Players, 2016
Fig. 7 Anticonvulsant Market for Trigeminal Neuralgia Treatment, 2015 - 2025 (US$ Mn)
Fig. 8 NSAIDs Market for Trigeminal Neuralgia Treatment, 2015 - 2025 (US$ Mn)
Fig. 9 Opioids Market for Trigeminal Neuralgia Treatment, 2015 - 2025 (US$ Mn)
Fig. 10 Rhizotomy Market for Trigeminal Neuralgia Treatment, 2015 - 2025 (US$ Mn)
Fig. 11 Rhizotomy Market for Trigeminal Neuralgia Treatment, 2015 - 2025 (US$ Mn)
Fig. 12 Rhizotomy Market for Trigeminal Neuralgia Treatment, 2015 - 2025 (US$ Mn)
Fig. 13 North America Trigeminal Neuralgia Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 14 Europe Trigeminal Neuralgia Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 15 Asia-Pacific Trigeminal Neuralgia Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 16 Latin America Trigeminal Neuralgia Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 17 Middle East and Africa Trigeminal Neuralgia Treatment Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Trigeminal Neuralgia Treatment Market, By Treatment, 2015-2025 (US$ Mn)
Table 2 Drug based treatment market for Trigeminal Neuralgia, 2015-2025 (US$ Mn)
Table 3 Surgery based treatment market for Trigeminal Neuralgia, 2015-2025 (US$ Mn)
Table 4 Global Trigeminal Neuralgia Treatment Market, by Geography, 2015 - 2025 (US$ Mn)
Table 5 Allergen Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 6 Biogen Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 7 Kineta Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments
Table 8 Merz Pharma GmbH & Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 9 Trigemina Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Development
Table 10 Abbot Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 11 Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 12 GlaxoSmithkline Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 13 Novartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 14 Shire: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan Plc
  • Biogen, Inc.
  • Kineta Inc.
  • Merz Pharma GmbH & Co.
  • Trigemina Inc.
  • Abbott Laboratories
  • Pfizer Inc.
  • GlaxoSmithKline Plc.
  • Novartis
  • Shire
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll